Paul MacLeman

Paul MacLeman

MBA, DVM, Grad Dip Eng, Grad Cert Eng, FAICD

Paul has over 25 years’ experience across all phases of the life sciences sector. With a career-spanning veterinary practice, pharmaceutical development and manufacturing, biotechnology, diagnostics and finance, Paul has expertise in capital raising, business development, technology commercialisation and sales & marketing globally. Paul has launched products using both in-house and outsourced sales staff in Australia and the US. He has founded life sciences start-ups in the biologics area and worked in investment banking focusing on the analysis and financing of technology companies. Paul has previously served as Chairman, Director or Managing Director/CEO of several VC funded, ASX, NASDAQ, CSE and TSX listed companies. Paul is currently Executive Chairman of Island Pharmaceuticals Ltd (ILA.ASX), is Chairman of AdAlta Limited (1AD:ASX) and Supertrans Medical Pty Ltd and Non-Executive Director of Upkara Pty Limited. Paul Chairs the Industry Review Committee for the Pharmaceutical Manufacturing National Training Package for the AISC. He is an expert advisor to PharmaVentures (Oxford, UK) and Mind Medicine. Paul also serves on a number of other NFP and government advisory groups.